CDK4 and neoplasm: Subsequent immunohistochemical analysis of subcutaneous tumor tissues obtained from mice administered with 5 mg/kg or 10 mg/kg of MGCD-265 revealed a reduction in levels of CDK4 and CDK6, accompanied by an elevation in levels of Cleaved caspase3 (Fig. 5D).